140 related articles for article (PubMed ID: 37942205)
1. Utility of Indigenously Developed Square Grid Method for Evaluation of Tumor-Stroma Ratio and Stromal Tumor-Infiltrating Lymphocytes in Invasive Breast Carcinoma: A Pilot Study.
Kumarguru BN; Ramaswamy AS; Arathi CA; Swathi D
Iran J Pathol; 2023; 18(3):335-346. PubMed ID: 37942205
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Tumor-Stroma Ratio and Tumor-Infiltrating Lymphocytes in Colorectal Cancer: Inter-Observer Agreement Evaluation.
Kazemi A; Gharib M; Mohamadian Roshan N; Taraz Jamshidi S; Stögbauer F; Eslami S; Schüffler PJ
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510083
[TBL] [Abstract][Full Text] [Related]
3. Investigating the role of core needle biopsy in evaluating tumor-stroma ratio (TSR) of invasive breast cancer: a retrospective study.
Le MK; Odate T; Kawai M; Oishi N; Kondo T
Breast Cancer Res Treat; 2023 Jan; 197(1):113-121. PubMed ID: 36335529
[TBL] [Abstract][Full Text] [Related]
4. Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression.
Van Berckelaer C; Rypens C; van Dam P; Pouillon L; Parizel M; Schats KA; Kockx M; Tjalma WAA; Vermeulen P; van Laere S; Bertucci F; Colpaert C; Dirix L
Breast Cancer Res; 2019 Feb; 21(1):28. PubMed ID: 30777104
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
O'Loughlin M; Andreu X; Bianchi S; Chemielik E; Cordoba A; Cserni G; Figueiredo P; Floris G; Foschini MP; Heikkilä P; Kulka J; Liepniece-Karele I; Regitnig P; Reiner A; Ryska A; Sapino A; Shalaby A; Stovgaard ES; Quinn C; Walsh EM; Zolota V; Glynn SA; Callagy G
Breast Cancer Res Treat; 2018 Aug; 171(1):1-9. PubMed ID: 29774470
[TBL] [Abstract][Full Text] [Related]
6. Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists.
Tramm T; Di Caterino T; Jylling AB; Lelkaitis G; Lænkholm AV; Ragó P; Tabor TP; Talman MM; Vouza E;
Acta Oncol; 2018 Jan; 57(1):90-94. PubMed ID: 29168428
[TBL] [Abstract][Full Text] [Related]
7. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Dano H; Altinay S; Arnould L; Bletard N; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchió C; Martinez DM; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban AM; Sinke R; Stanciu-Pop CM; Stobbe C; van Deurzen CHM; Van de Vijver K; Van Rompuy AS; Verschuere S; Vincent-Salomon A; Wen H; Bouzin C; Galant C; Van Bockstal MR
Mod Pathol; 2020 Mar; 33(3):354-366. PubMed ID: 31534203
[TBL] [Abstract][Full Text] [Related]
8. e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study.
Smit MA; van Pelt GW; Dequeker EM; Al Dieri R; Tollenaar RA; van Krieken JHJ; Mesker WE;
JMIR Form Res; 2021 Mar; 5(3):e19408. PubMed ID: 33739293
[TBL] [Abstract][Full Text] [Related]
9. Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer.
Choi S; Cho SI; Jung W; Lee T; Choi SJ; Song S; Park G; Park S; Ma M; Pereira S; Yoo D; Shin S; Ock CY; Kim S
NPJ Breast Cancer; 2023 Aug; 9(1):71. PubMed ID: 37648694
[TBL] [Abstract][Full Text] [Related]
10. Computerized Assessment of the Tumor-stromal Ratio and Proposal of a Novel Nomogram for Predicting Survival in Invasive Breast Cancer.
Qian X; Xiao F; Chen YY; Yuan JP; Liu XH; Wang LW; Xiong B
J Cancer; 2021; 12(12):3427-3438. PubMed ID: 33995621
[No Abstract] [Full Text] [Related]
11. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
[TBL] [Abstract][Full Text] [Related]
12. Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
Swisher SK; Wu Y; Castaneda CA; Lyons GR; Yang F; Tapia C; Wang X; Casavilca SA; Bassett R; Castillo M; Sahin A; Mittendorf EA
Ann Surg Oncol; 2016 Jul; 23(7):2242-8. PubMed ID: 26965699
[TBL] [Abstract][Full Text] [Related]
13. Proposal of an automated tumor-stromal ratio assessment algorithm and a nomogram for prognosis in early-stage invasive breast cancer.
Xu Q; Chen YY; Luo YH; Zheng JS; Lin ZH; Xiong B; Wang LW
Cancer Med; 2023 Jan; 12(1):131-145. PubMed ID: 35689454
[TBL] [Abstract][Full Text] [Related]
14. Inter-observer agreement of tumor infiltrating lymphocytes in primary HER2-positive breast cancer and correlation between tissue microarray and full tumor-sections.
Reznitsky FM; Jensen JD; Knoop A; Laenkholm AV
APMIS; 2022 Sep; 130(9):545-550. PubMed ID: 35639634
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
[TBL] [Abstract][Full Text] [Related]
16. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
Eriksen AC; Andersen JB; Lindebjerg J; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB
Diagn Pathol; 2018 Mar; 13(1):20. PubMed ID: 29558947
[TBL] [Abstract][Full Text] [Related]
17. The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Van Berckelaer C; Vermeiren I; Vercauteren L; Rypens C; Oner G; Trinh XB; Tjalma WAA; Broeckx G; Charafe-Jauffret E; Van Laere S; Bertucci F; Colpaert C; van Dam PA
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572883
[TBL] [Abstract][Full Text] [Related]
18. Standardized Assessment of the Tumor-Stroma Ratio in Colorectal Cancer: Interobserver Validation and Reproducibility of a Potential Prognostic Factor.
Souza da Silva RM; Queiroga EM; Paz AR; Neves FFP; Cunha KS; Dias EP
Clin Pathol; 2021; 14():2632010X21989686. PubMed ID: 33634262
[TBL] [Abstract][Full Text] [Related]
19. Interobserver reproducibility of tumor-infiltrating lymphocyte evaluations in breast cancer.
Cabuk FK; Aktepe F; Kapucuoglu FN; Coban I; Sarsenov D; Ozmen V
Indian J Pathol Microbiol; 2018; 61(2):181-186. PubMed ID: 29676353
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
